Prime Medicine, Inc. (PRME)
NASDAQ: PRME · IEX Real-Time Price · USD
5.31
-0.27 (-4.76%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $636.76 million as of July 22, 2024. Its market cap has decreased by -52.33% in one year.
Market Cap
636.76M
Enterprise Value
456.34M
1-Year Change
-52.33%
Ranking
Category
Stock Price
$5.31
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $636.76M, a decrease of -60.87%. That is a compound annual growth rate of -41.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 636.80M | -26.15% |
| Dec 29, 2023 | 862.30M | -52.26% |
| Dec 30, 2022 | 1.81B | 10.98% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UroGen Pharma | 650.07M |
| Exscientia | 649.15M |
| Acelyrin | 644.67M |
| Arcturus Therapeutics Holdings | 640.71M |
| Phathom Pharmaceuticals | 640.67M |
| IGM Biosciences | 633.91M |
| Pediatrix Medical Group | 632.79M |
| PetIQ | 630.85M |